Logo
For Sales: 888.816.4721 | Contact Us

WorldCare Clinical Names Scientific Advisory Board Members

June 06, 2006

WorldCare Clinical, LLC (WCC), a central imaging core lab that specializes in the expert interpretation, measurement, and analysis of medical images as a proven strategy for accelerating clinical trials, today announced the appointment of ten members of its Scientific Advisory Board.

Originally conceived by the Massachusetts General Hospital (MGH) Department of Radiology to provide drug development services to the pharmaceutical and medical device industries, WorldCare Clinical was created by MGH in 1992 under a different name and then spun off in 1995.

In a related development, Cincinnati-based ProScan Imaging, LLC, announced today that it has acquired 51-percent ownership of WCC from its parent company, WorldCare Limited, a pioneer and leader in the development, commercialization, and distribution of global e-health services and solutions. Under the new partnership arrangement, WorldCare Limited will retain 49-percent ownership and WCC’s headquarters will remain in Cambridge.

Following the ownership change, the following Scientific Advisory Board members have accepted offers to participate:

  • Leslie Shu-Tung Fang, M.D., Chairman. Dr. Fang is an Assistant Clinical Professor of Medicine at the MassachusettsGeneral Hospital and Harvard Medical School, and lectures extensively on antibiotics and analgesics. He also holds a Ph.D. degree in physiology and biophysics.
  • Giles Boland, M.D. Dr. Boland is Director of Teleradiology at Massachusetts General Hospital and an Associate Professor in Radiology at Harvard Medical School.
  • Gordon F. Brunner. Mr. Brunner retired from Procter & Gamble after 40 years service. He served as Chief Technology Officer and Senior Vice President in charge of global research and development, and a member of the P&G Board of Directors. Among his accomplishments were overseeing the evolution of an internally developed major pharmaceutical business and the creation of the largest global over-the-counter medicine business.
  • Jeffrey Gelfand, M.D. Dr. Gelfand is a Senior Advisor on International Medical Affairs at the Partners Healthcare System and Director of the International Program of the Center for the Integration of Medicine and Innovative Technology.
  • Ephraim Hochberg, M.D. Dr. Hochberg is an instructor at both Harvard Medical School and Massachusetts General Hospital, board-certified in medical oncology and hematology.
  • Fred Hochberg, M.D. Dr. Hochberg is a specialist in neuro-oncology at the Massachusetts General Hospital. He is co-Principal Investigator of the NCI Consortium, New Approaches in Brain Tumor Therapy. His expertise is in the diagnosis and treatment of tumors of the nervous system and the provision of experimental therapies.
  • Homer Pien, Ph.D. Dr. Pien is Managing Director of the Center for Biomarkers in Imaging, operating under the Radiology Department of Massachusetts General Hospital. He is an expert in medical image and signal processing, is an instructor in the Harvard Medical School Department of Radiology, and an Adjunct Professor in the Graduate College of Computer Science at Northeastern University.
  • Stephen Pomeranz, M.D. Dr. Pomeranz is founder, Chief Executive Officer, and Medical Director of ProScan Imaging, LLC. Through the ProScan MRI Education Foundation, he has taught 16,000 physicians at fully accredited continuing medical education courses and seminars presented worldwide.
  • Hassan S. Sharif, M.D., F.R.C.R. Dr. Sharif has been the Chief Executive Officer of WorldCare Clinical and was one of the co-founders of WorldCare International, where he serves as Chief Medical Officer and Chief Operating Officer.
  • David Thomas, M.S. Mr. Thomas is Chairman and CEO of Sierra Scientific Software, Inc. For more than 30 years David Thomas has participated in clinical research. He has established and directed clinical programs to qualify new products and obtain FDA approvals.

“We are privileged to have such distinguished advisors, all of whom are widely recognized experts in their respective fields,” said Rafael Mancera, WCC’s new Chief Executive Officer.”

Utilizing the most advanced imaging technologies available, WCC assembles teams with world-class therapeutic expertise in a wide range of disease states to deliver comprehensive drug development services. From protocol design through data delivery, WCC provides evaluations to leading pharmaceutical, biotechnology, medical device and clinical research organizations worldwide.

“Not only are we able to design and execute imaging trials using the appropriate modality for the disease,” said Rick Taranto, President of WorldCare Clinical, “but our design services combine the foremost therapeutic expertise of MGH physicians with the practical core lab experience and technology of WorldCare Clinical. Through our imaging services, we can deliver comprehensive solutions to the development needs of drug and medical device manufacturers.”

Massachusetts General Hospital, the oldest and largest teaching hospital of Harvard Medical School, has had a strategic relationship with WorldCare Clinical since its inception in 1992. The Department of Radiology at MGH has provided services to the pharmacology companies that utilize WCC as their image core lab. This relationship will continue and grow.

Founded in 1811, MGH is recognized as a world leader in academic medicine and has made pivotal contributions to the advancement of medicine throughout history. The third-oldest hospital in the United States, MGH today provides sophisticated, multidisciplinary diagnostic and therapeutic care in every medical specialty and subspecialty. The hospital system employs over 3,700 specialist and sub-specialist physicians and maintains 893 acute-care beds. Its professional staff treated 44,518 patients and 1,440,766 outpatients and performed 32,650 surgical procedures in 2003 alone.